From New York to Dublin, through Amsterdam to Bermuda—how one pharmaceutical company avoids a third of its U.S. income taxes by moving its money around the world
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.